Screener
Kura Oncology KURA Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $20.87M+36.5% | $18.27M+29.5% | $17.34M+28.7% | $20.75M+54.0% | $15.29M+13.5% | ||
| $243K— | $262K— | —— | —— | —— | ||
| $20.63M— | $18M— | —— | —— | —— | ||
| 98.8%— | 98.6%— | —— | —— | —— | ||
| $61.89M-1.4% | $65.26M+16.6% | $64.41M+23.2% | $67.91M+62.8% | $62.79M+58.0% | ||
| $31.75M+26.1% | $31.56M+38.2% | —— | —— | $25.17M+30.6% | ||
| $93.88M+6.7% | $97.08M+23.2% | —— | —— | $87.95M— | ||
| -$73.01M-0.5% | -$78.82M-21.8% | -$86.27M-284% | -$80M-33.6% | -$72.67M-28.8% | ||
| -349.8%+126pp | -431.5%+27.1pp | -497.6%-331pp | -385.5%+59.0pp | -475.3%-56.6pp | ||
| $345K-11.8% | $336K-12.0% | $346K-14.1% | $393K-4.6% | $391K-3.7% | ||
| $4.69M-28.4% | $5.49M-26.8% | $5.34M+1.6% | $5.88M+7.3% | $6.54M+17.5% | ||
| -$68.32M-3.3% | -$73.33M-28.2% | -$80.93M-371% | -$74.12M-36.2% | -$66.12M-30.1% | ||
| $5K— | $8K-96.5% | $71K-85.9% | —— | —— | ||
| -$68.33M-3.3% | -$73.33M-27.7% | -$81M-321% | -$74.12M-36.2% | -$66.12M-30.1% | ||
| -327.3%+105pp | -401.5%+5.6pp | -467.2%-325pp | -357.2%+46.7pp | -432.5%-55.1pp | ||
| -$0.77-2.7% | -$0.83-25.8% | -$0.92-318% | -$0.85-34.9% | -$0.75-27.1% | ||
| -$72.64M-0.3% | -$78.46M-21.7% | -$85.87M-286% | -$79.83M-33.8% | -$72.44M-28.9% | ||
| -348%+126pp | -429.6%+27.3pp | -495.3%-330pp | -384.7%+58.3pp | -473.8%-56.6pp | ||
| -$73.01M-0.5% | -$78.82M-21.8% | -$86.27M-284% | -$80M-33.6% | -$72.67M-28.8% |
FAQ
- What is Kura Oncology's revenue?
- Kura Oncology (KURA) generated $77.2M in revenue over the trailing twelve months, up 37.1% year over year.
- Is Kura Oncology profitable?
- Kura Oncology is not currently profitable: it reported a net loss of $296.8M over the trailing twelve months, a -384.3% net margin.
- What is Kura Oncology's earnings per share?
- Kura Oncology's diluted EPS over the trailing twelve months is $-3.37.
- Where does Kura Oncology's income statement data come from?
- Every line is extracted from Kura Oncology's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
